[ 1 ] Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology[J]. Ann Intern Med, 1998, 129(3): 182-189.
[ 7 ] Dent LL,Marshall DR,Pratap S, et al. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital[J]. BMC Infect Dis, 2010, 10: 196.
[ 9 ] Jung JY, Park MS, Kim SE, et al. Risk factors for multidrug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit[J]. BMC Infect Dis, 2010, 10: 228.
[7]
Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J]. J Antimicrob Chemother, 2003, 51(3): 565-574.